PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/cpt.2376
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 34314511
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34314511>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34314511>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all